Table 1.
Protease | Source | Classification | Activity/mechanism | Disease | Ref |
---|---|---|---|---|---|
Proteases released by bacteria | |||||
Collagenase A | Clostridium perfringens | Metalloprotease | Intestinal barrier alteration/mucus | IBD | 124 |
Dipeptidyl peptidase IV Dipeptidase Amino peptidase C Tricorn protease homolog |
Bacteroides/ B. vulgatus | Serine protease Metalloprotease Cysteine protease |
Contribute to UC disease activity, barrier dysfunction | IBD | 32,33 |
ND | R. mucilaginosa | ND | Gluten degradation | CeD | 47 |
ND | Lactobacillus | ND | ATI peptides/gluten degradation | CeD | 101 |
LasB | P. aeruginosa | Zn metalloprotease | Gluten degradation, PAR-2 mediated signaling Intestinal barrier alteration Degrade IL-2 and IFN-γ |
CeD and others | 18,146,162 |
Prolyl endopeptidases |
F. meningosepticum S. capsulate M. xanthus |
Serine peptidases | Gluten degradation | CeD | 49 |
BAV86562.1 Subtilisin family |
R. aeria | Serine protease | Gluten degradation | CeD | 48 |
GeIE | E. faecalis | Metalloprotease | Compromise epithelial barrier | Colitis mouse model | 131 |
SP-1 | C. ramosum | Serine protease | Epithelial barrier dysfunction | Colitis mouse model | 129 |
HtrA |
H. pylori C. jejuni S. Typhimurium |
Serine protease | Epithelial barrier alteration Growth and infection |
Gastrointestinal infection | 63,80,81 |
PqqE | H. pylori | Zn metalloprotease | Gastrointestinal infection | ||
Haemagglutinin or vibriolysin | V. cholerae | Metalloprotease | Barrier integrity alteration/actin and tight junction rearrangement | Gastrointestinal infection | 83 |
SepA |
S. flexneri E. coli |
Serine protease | Barrier dysfunction/invasion | Gastrointestinal infection | 72 |
Pic |
E. coli Citrobacter S. flexneri |
Serine protease | Disrupt mucosal barriers/modulate immune response/ mucinase activity |
Gastrointestinal infection | 68–71 |
SslE | E. coli | Zn metalloprotease | Mucin degradation | Gastrointestinal infection | 76 |
StcE | E. coli | Metalloproteases | Mucus degradation | Gastrointestinal infection | 74,75 |
ND | L. pneumophila | Zn Metalloproteases | Degrade IL-2 | Gastrointestinal infections | 148 |
PROKKA_00509 | Paraprevotella | ND | Trypsin degradation | Others | 9 |
M60-like proteases | B. caccae | Metalloproteases | Mucin degradation | Other | 127 |
M60-like/PF13402 domain | B. thetaiotaomicron | Metalloprotease | Mucin degradation | Others | 125 |
ZmpB | C. perfringens | Zn metalloproteases | Mucus degradation | Others | 117 |
Proteases released by the host | |||||
Aminopeptidase B | Human colonic tissues | Metalloprotease | Lysine-cleaving protease identified as active in CD | IBD | 8 |
Cathepsin G | Human colonic tissue | Serine protease | Overactive | IBD | 8 |
Human stool | Epithelial barrier alteration | IBD | 28 | ||
Dipeptidyl Peptidase-4 | Human stool/intestinal tissue | Serine protease | Increased levels and expression | IBD | 163 |
ELA 2A (Elastase 2A) |
Human colonic cells | Serine protease | Epithelial barrier dysfunction | IBD | 29 |
Thrombin | Human colonic tissue | Serine protease | Overactive | IBD | 8 |
Trypsin-like, Elastase-like Cathepsin G-like Proteinase 3-like |
Human stool | Serine proteases | Elevated activity | IBD | 12 |
Kallikrein | Human intestinal tissue/stool | Serine protease | Inflammatory process in Crohn’s disease. | IBD/IBS | 13,164 |
Trypsin-like Chymotrypsin-like Elastase-like |
Human stool | Serine protease | Elevated in patients with high proteolytic activity | IBS | 13 |
Trypsin-3/Trypsin-like activity | Human colonic tissue | Serine protease | Upregulated in intestinal epithelial, signal to enteric neurons and to induce visceral hypersensitivity/somatic and visceral hyperalgesia and allodynia in colon mice | IBS | 7,58 |
Tryptase-alphabeta-1/Tryptase | Rat colonic tissue | Serine protease | Expression increased in colon of rats pots-colitis with visceral hypersensitivity/somatic and visceral hyperalgesia and allodynia in colon mice | IBS | 31, 58 |
ND = Not determined